LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $50,588,000 | +11.8% | 472,386 | +12.9% | 0.09% | +12.7% |
| Q4 2015 | $45,266,000 | +42.3% | 418,475 | +12.7% | 0.08% | +33.9% |
| Q3 2015 | $31,814,000 | -3.4% | 371,436 | +13.8% | 0.06% | +11.3% |
| Q2 2015 | $32,944,000 | +14.7% | 326,514 | -12.4% | 0.05% | 0.0% |
| Q1 2015 | $28,732,000 | +62.4% | 372,609 | +10.0% | 0.05% | +71.0% |
| Q4 2014 | $17,696,000 | +19.7% | 338,855 | +7.7% | 0.03% | +19.2% |
| Q3 2014 | $14,782,000 | +36.7% | 314,559 | +43.2% | 0.03% | +36.8% |
| Q2 2014 | $10,816,000 | -14.4% | 219,635 | +16.9% | 0.02% | -13.6% |
| Q1 2014 | $12,633,000 | +21.7% | 187,814 | +9.1% | 0.02% | +15.8% |
| Q4 2013 | $10,378,000 | +273.4% | 172,129 | +168.0% | 0.02% | +280.0% |
| Q3 2013 | $2,779,000 | 0.0% | 64,223 | -13.5% | 0.01% | 0.0% |
| Q2 2013 | $2,779,000 | – | 74,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |